Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based ...

The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...

Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

Hereditary breast cancer due to genetic mutations accounts for 5% to 10% of breast cancers. Breast cancer is the most ...

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Thursday, ...

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

Thank you, Jenny, and good morning, everyone. Welcome to the NeoGenomics Third Quarter 2025 Financial Results Call. With me today to discuss the results are Tony Zook, Chief Executive Officer; and ...

Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...